Taubman Scholar Dr. David Ginsburg to receive Stratton Medal
The American Society of Hematology (ASH) will recognize David Ginsburg, M.D., with the 2012 Henry M. Stratton Medal for his accomplishments in the fields of thrombosis and blood cell immunology.
Dr. Ginsburg is a Taubman Scholar and the James V. Neel Distinguished Professor of Internal Medicine and Human Genetics at the University of Michigan Medical School.
The Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH’s journal Blood. The prize honors senior investigators whose contributions to hematology are well-recognized and have taken place over a period of several years.
This year, for the first time, the Stratton Medal will be awarded to two individuals, one in basic research and the other in clinical/translational research. Ginsburg will receive the 2012 Stratton Medal for Basic Research for his many seminal scientific contributions in characterizing the molecular and genetic basis of inherited bleeding and clotting disorders. Dr. Richard H. Aster, M.D., of the Blood Center of Wisconsin and Medical College of Wisconsin in Milwaukee will receive the 2012 Stratton Medal for Clinical/Translational Research.
Read the entire University of Michigan Health System press release here.
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
- May 06, 2013
- May 06, 2013
- May 03, 2013
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.